August 2023 FDA Recall Clearasil Rapid Rescue Deep Treatment Pads by Rb Health (us) Llc (D-1179-2023 - Labeling)
This Class III drug recall was voluntarily initiated by Rb Health (us) Llc on August 29, 2023 for the product Clearasil Rapid Rescue Deep Treatment Pads. The FDA reported the reason for recall as labeling. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-1179-2023
Labeling: Label Error on Declared Strength: The incorrect label on the back of the product packaging.
08-29-2023
10-04-2023
6,072 cases/36,426 individual selling units
Recall Profile & Regulatory Data
Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
RB Health (US) LLC
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
USA nationwide
04-22-2025
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Clearasil Rapid Rescue Deep Treatment Pads (Salicylic Acid 2%), packaged in 90-count plastic jar, further packaged in case of 6 jars per case, Distributed by RB Health (US), Parsippany, NJ 07054, NDC 63824-431-90
Batch or Lot Expiration Information
Lot# KT220211, Exp 07/2024